980
(2S)-1-(4-{[2-(2-aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}piperazin-1-yl)-2-hydroxypropan-1-one
Find entries where: 980
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
|---|---|
| Name | (2S)-1-(4-{[2-(2-aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}piperazin-1-yl)-2-hydroxypropan-1-one |
| Identifiers | (2S)-1-[4-[[2-(2-azanylpyrimidin-5-yl)-7-methyl-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-oxidanyl-propan-1-one |
| Formula | C23 H30 N8 O3 S |
| Molecular Weight | 498.60 |
| Type | NON-POLYMER |
| Isomeric SMILES | Cc1c(sc2c1nc(nc2N3CCOCC3)c4cnc(nc4)N)CN5CCN(CC5)C(=O)[C@H](C)O |
| InChI | InChI=1S/C23H30N8O3S/c1-14-17(13-29-3-5-31(6-4-29)22(33)15(2)32)35-19-18(14)27-20(16-11-25-23(24)26-12-16)28-21(19)30-7-9-34-10-8-30/h11-12,15,32H,3-10,13H2,1-2H3,(H2,24,25,26)/t15-/m0/s1 |
| InChIKey | YOVVNQKCSKSHKT-HNNXBMFYSA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 65 |
| Chiral Atom Count | 1 |
| Bond Count | 69 |
| Aromatic Bond Count | 16 |
Drug Info: DrugBank
| DrugBank ID | DB12180 |
|---|---|
| Name | Apitolisib |
| Groups | investigational |
| Description | Apitolisib has been used in trials studying the treatment of Solid Cancers, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, and Endometrial Carcinoma, among others. |
| Synonyms |
|
| Categories | Phosphatidylinositol 3-Kinase, antagonists & inhibitors |
| CAS number | 1032754-93-0 |
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 25254071 |
| ChEMBL | CHEMBL1922094 |
| Pharos | CHEMBL1922094 |
